Matches in SemOpenAlex for { <https://semopenalex.org/work/W2399502693> ?p ?o ?g. }
- W2399502693 endingPage "991" @default.
- W2399502693 startingPage "983" @default.
- W2399502693 abstract "Irritable bowel syndrome is a functional gastrointestinal disorder with a multifactorial etiology. Alterations of intestinal motility and immunity, gut-brain interactions, as well as gut microbiota dysbiosis contribute to the development of irritable bowel syndrome. Therefore, gut microbiota modulation by non-absorbable antibiotics is a therapeutic option in patients with IBS.Published articles including patients with irritable bowel syndrome reporting data about rifaximin activity and safety have been searched throughout the literature and selected.The optimal antibiotic molecule should be local-acting, long-acting and safe-acting. Rifaximin is a non-absorbable antibiotic with additional anti-inflammatory and gut microbiota-modulating activity. It is effective in inducing symptoms relief in patients with IBS, even after repeated treatment courses. Rifaximin-related side effects in patients with IBS are reported to be mild and infrequent; microbial resistance is rare and transient, due to the high local concentration of the drug and to the absence of horizontal transmission. Clostridium difficile infection is not usual in patients receiving rifaximin in absence of predisposing conditions such as hospitalization and immunosuppression, which are uncommon in patients affected by irritable bowel syndrome. Nevertheless rifaximin is an antibiotic active against Clostridium difficile infection. Rifaximin has limited metabolic interactions and is not expected to interfere with drug metabolism in patients with normal hepatic function. These properties make rifaximin a safe antibiotic for gut microbiota modulation in patients with IBS." @default.
- W2399502693 created "2016-06-24" @default.
- W2399502693 creator A5038472987 @default.
- W2399502693 creator A5049932280 @default.
- W2399502693 creator A5051347954 @default.
- W2399502693 creator A5063416087 @default.
- W2399502693 creator A5078126497 @default.
- W2399502693 creator A5085399427 @default.
- W2399502693 date "2016-05-23" @default.
- W2399502693 modified "2023-09-26" @default.
- W2399502693 title "Rifaximin for the treatment of irritable bowel syndrome – a drug safety evaluation" @default.
- W2399502693 cites W105760296 @default.
- W2399502693 cites W1483462250 @default.
- W2399502693 cites W1498952305 @default.
- W2399502693 cites W1576640379 @default.
- W2399502693 cites W1851970679 @default.
- W2399502693 cites W1853321481 @default.
- W2399502693 cites W1976224228 @default.
- W2399502693 cites W1980174157 @default.
- W2399502693 cites W1981417697 @default.
- W2399502693 cites W1996001370 @default.
- W2399502693 cites W1999969457 @default.
- W2399502693 cites W2002444117 @default.
- W2399502693 cites W2002724414 @default.
- W2399502693 cites W2003796334 @default.
- W2399502693 cites W2008054523 @default.
- W2399502693 cites W2010459511 @default.
- W2399502693 cites W2012606594 @default.
- W2399502693 cites W2018878564 @default.
- W2399502693 cites W2021385518 @default.
- W2399502693 cites W2023123778 @default.
- W2399502693 cites W2024601462 @default.
- W2399502693 cites W2025873491 @default.
- W2399502693 cites W2026317976 @default.
- W2399502693 cites W2031365879 @default.
- W2399502693 cites W2035174162 @default.
- W2399502693 cites W2047118920 @default.
- W2399502693 cites W2049004338 @default.
- W2399502693 cites W2051060917 @default.
- W2399502693 cites W2056196379 @default.
- W2399502693 cites W2056304431 @default.
- W2399502693 cites W2056318268 @default.
- W2399502693 cites W2061365505 @default.
- W2399502693 cites W2061492469 @default.
- W2399502693 cites W2064201279 @default.
- W2399502693 cites W2067788101 @default.
- W2399502693 cites W2074514990 @default.
- W2399502693 cites W2077005896 @default.
- W2399502693 cites W2077623116 @default.
- W2399502693 cites W2078752617 @default.
- W2399502693 cites W2078774068 @default.
- W2399502693 cites W2080071878 @default.
- W2399502693 cites W2092038168 @default.
- W2399502693 cites W2094665977 @default.
- W2399502693 cites W2097177097 @default.
- W2399502693 cites W2098202807 @default.
- W2399502693 cites W2098517148 @default.
- W2399502693 cites W2099360240 @default.
- W2399502693 cites W2100507037 @default.
- W2399502693 cites W2103771013 @default.
- W2399502693 cites W2106225676 @default.
- W2399502693 cites W2109524284 @default.
- W2399502693 cites W2110147288 @default.
- W2399502693 cites W2112679280 @default.
- W2399502693 cites W2120356061 @default.
- W2399502693 cites W2120896017 @default.
- W2399502693 cites W2125024218 @default.
- W2399502693 cites W2125894152 @default.
- W2399502693 cites W2130488316 @default.
- W2399502693 cites W2133715751 @default.
- W2399502693 cites W2133926562 @default.
- W2399502693 cites W2141125135 @default.
- W2399502693 cites W2141397074 @default.
- W2399502693 cites W2141439571 @default.
- W2399502693 cites W2149216059 @default.
- W2399502693 cites W2151028255 @default.
- W2399502693 cites W2152359084 @default.
- W2399502693 cites W2154745198 @default.
- W2399502693 cites W2166623682 @default.
- W2399502693 cites W2176306270 @default.
- W2399502693 cites W2194277343 @default.
- W2399502693 cites W2319692768 @default.
- W2399502693 cites W2319922781 @default.
- W2399502693 cites W2387394128 @default.
- W2399502693 cites W2404343343 @default.
- W2399502693 cites W4251432129 @default.
- W2399502693 doi "https://doi.org/10.1080/14740338.2016.1186639" @default.
- W2399502693 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27149541" @default.
- W2399502693 hasPublicationYear "2016" @default.
- W2399502693 type Work @default.
- W2399502693 sameAs 2399502693 @default.
- W2399502693 citedByCount "16" @default.
- W2399502693 countsByYear W23995026932017 @default.
- W2399502693 countsByYear W23995026932018 @default.
- W2399502693 countsByYear W23995026932019 @default.
- W2399502693 countsByYear W23995026932020 @default.
- W2399502693 countsByYear W23995026932021 @default.
- W2399502693 countsByYear W23995026932023 @default.